SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA...
Toronto, Ontario--(Newsfile Corp. - June 8, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as a once-weekly injection and a...
FOUNTAIN VALLEY, Calif., June 5, 2026 /PRNewswire/ -- AVIA, the leading digital transformation partner in healthcare, today announced that MemorialCare...
Developed with 20+ partners across industry, advocacy, and research, the resources give drug developers, regulators, payors, and clinicians a shared...
Free Memory Screenings Offered Across the Country during Alzheimer’s and Brain Awareness MonthWASHINGTON, June 04, 2026 (GLOBE NEWSWIRE) -- Alzheimer’s...
AHZANTIVE® (aflibercept) is an EMA-approved biosimilar to Eylea® (aflibercept) with demonstrated similarity in efficacy, safety and immunogenicity to the reference product The launch expands Teva’s biosimilars portfolio and presence in ophthalmology, in line with the Company’s...
NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era...
BOWIE, Md., June 3, 2026 /PRNewswire/ -- The Epilepsy Foundation of America is proud to announce that Joyce A. Cramer...
Collaboration's initial focus will focus on two antibody programs targeting CNS diseases VALBY, Denmark and AMSTERDAM, June 3, 2026 /PRNewswire/ --...
SAN DIEGO, June 03, 2026 (GLOBE NEWSWIRE) -- Denovo Neuroscience, a pioneer in applying precision medicine in central nervous system...
SAN DIEGO, June 03, 2026 (GLOBE NEWSWIRE) -- Denovo Neuroscience, a pioneer in applying precision medicine in central nervous system...
New findings from the industry’s largest real-world TMS database reinforce NeuroStar’s leadership in advancing evidence-based mental health careMALVERN, Pa., June...
XPro1595 showed a highly significant treatment effect in the full mITT population (p=0.0028; d=0.46; n=200), demonstrating broad tissue-level target engagement...
– Comes just weeks after Firefly confirmed its active public-private partnership with the U.S. Department of War – KENMORE, N.Y,...
Presentation by leading expert Andrew J. Cutler, MD, will examine the lifelong impact of ADHD, risks of leaving the condition...
Further Strengthens Company’s Medical Depth and Therapeutic ExpertiseMORRISVILLE, N.C., May 28, 2026 (GLOBE NEWSWIRE) -- Syneos Health®, a leading fully...
ROSELAND, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug...
Hartford HealthCare becomes one of the first clinically integrated networks in the region to include MinuteClinic as an in-network primary...
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 25, 2026...